CN113552366A - IV-type collagen determination kit and preparation method thereof - Google Patents

IV-type collagen determination kit and preparation method thereof Download PDF

Info

Publication number
CN113552366A
CN113552366A CN202110768501.4A CN202110768501A CN113552366A CN 113552366 A CN113552366 A CN 113552366A CN 202110768501 A CN202110768501 A CN 202110768501A CN 113552366 A CN113552366 A CN 113552366A
Authority
CN
China
Prior art keywords
kit
reagent
collagen
buffer solution
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110768501.4A
Other languages
Chinese (zh)
Other versions
CN113552366B (en
Inventor
何秋富
陈壮洪
邢力策
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Yapei Biotechnology Co ltd
Original Assignee
Zhejiang Yapei Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Yapei Biotechnology Co ltd filed Critical Zhejiang Yapei Biotechnology Co ltd
Priority to CN202110768501.4A priority Critical patent/CN113552366B/en
Publication of CN113552366A publication Critical patent/CN113552366A/en
Application granted granted Critical
Publication of CN113552366B publication Critical patent/CN113552366B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to an IV type collagen determination kit and a detection method thereof. The IV type collagen detection kit provided by the invention is used by combining the surfactants, improves the stability of the reagent, simultaneously considers the detection sensitivity, greatly improves the linear range of detection, obviously improves the sensitivity and stability of the detection reagent, is suitable for various full-automatic biochemical analyzers for analysis, and has good adaptability.

Description

IV-type collagen determination kit and preparation method thereof
Technical Field
The invention relates to the technical field of in-vitro diagnostic reagents, in particular to an IV type collagen determination kit and a detection method thereof.
Background
Collagen is a fibrillar glycoprotein, which is a peptide chain network formed by triple helix. It has been found that up to 10 kinds of collagen exist in different tissues. Type iv collagen is an important component constituting the basement membrane. The normal intrahepatic basement membrane is mainly present around blood vessels, lymphatic vessels and bile ducts, and is absent from the hepatic sinus wall. The fibrous tissue has life-prolonging life-span along with the development of inflammation in the liver disease, a large amount of collagen is deposited in the fibrous tissue generation process, various collagens are increased, a basement membrane is proliferated, type IV collagen is proliferated firstly in the proliferated collagens, the conversion rate is high, a fibrous clapboard is easy to form, the normal liver lobule structure is damaged, the liver lobules are reconstructed, and false lobules are formed, so that the liver cirrhosis is caused.
The IV type collagen has obvious change in hepatic fibrosis, and when the total collagen amount in mild hepatic injury and hepatic fibrosis is not obviously increased, the content of the serum IV type collagen can be obviously increased, and the change of the content can better reflect hepatic fibrosis and hepatic cell injury and degree.
Diagnosis of early stage hepatic fibrosis or fibrosis of other organs. Type IV collagen is an index mainly used for observing liver cirrhosis, the concentration of the type IV collagen is related to the degree of liver fibrosis, and the degree of the liver cirrhosis can be presumed from the serum type IV collagen concentration.
1. In acute hepatitis, although a large amount of liver cells are destroyed, the concentration of serum IV type collagen has no obvious difference with that of a healthy person because of no obvious connective tissue hyperplasia.
2. The serum IV type collagen of patients with chronic hepatitis, liver cirrhosis and liver cancer is obviously increased, and the increased degree is primary liver cancer, liver cirrhosis, chronic active hepatitis, chronic persistent hepatitis and acute viral hepatitis. At present, the known kit for detecting serum IV type collagen is less, the traditional method has larger defects, the determination sensitivity is insufficient, the operation is complicated, the accuracy is low, and the like, and the clinical popularization and the use are not facilitated.
At present, IV type collagen detection reagents with high sensitivity and strong specificity, in particular to automatic detection reagents with good quality, are lacked in the market. The existing IV type collagen determination method mainly uses a time-resolved fluorescence immunochromatography method, a chemiluminescence immunoassay method and the like. The time-resolved fluorescence immunochromatography method has good stability but low sensitivity; the chemiluminescence method has high sensitivity, but the reagent has poor stability, needs expensive special chemiluminescence detection equipment, is not beneficial to development in a conventional laboratory, and has obvious limitation on clinical application. Although the existing latex immunoturbidimetry is simple and rapid to operate, the sensitivity is low and the linear range is narrow. Therefore, it is urgently needed to develop a type IV collagen detection reagent kit with high sensitivity, strong specificity, simple detection method and wide application range.
Disclosure of Invention
According to previous studies by the inventors, it was found that there was a clear correlation between the surfactant and the binding of type IV collagen to the antibody. In order to overcome the defects in the prior art, the invention provides a type IV collagen determination kit, which comprises a surfactant, a stabilizer, a buffer solution, a type IV collagen antibody and an antifreeze agent which are combined.
In one embodiment, the surfactant of the present invention is a combination of both F88 and polyoxyethylene lauryl ether, preferably, the ratio of F88 to polyoxyethylene lauryl ether is 1: 1.
In one embodiment, the stabilizing agent in the present invention is one or more selected from inorganic salts, preservatives, and cell protective agents;
in one embodiment, the inorganic salt in the present invention is one or more of sodium chloride, potassium chloride or magnesium chloride, preferably, the inorganic salt in the present invention is sodium chloride;
in one embodiment, the preservative in the present invention is one of Proclin 300, benzoic acid, sodium benzoate, and sodium azide, and preferably, the preservative in the present invention is Proclin 300;
in one embodiment, the buffer solution in the present invention is one or more of a phosphate buffer solution, a tris (hydroxymethyl) aminomethane sulfonic acid (TAPS) buffer solution, and an acetate buffer solution, and preferably, the buffer solution in the present invention is a phosphate buffer solution;
in one embodiment, the cytoprotective agent of the present invention is one or more selected from ovalbumin, bovine transferrin, human serum albumin, bovine serum albumin and hemocyanin, and preferably, the cytoprotective agent of the present invention is bovine serum albumin.
In one embodiment, the collagen type iv antibodies of the invention are derived from an animal or a recombinant antibody, such as rabbit, sheep, chicken, camel, mouse, rat. Most preferably, the collagen type IV antibody of the invention is a rabbit anti-human collagen type IV antibody.
In one embodiment, the type iv collagen antibody may be selected from type iv collagen antibody latex microsphere particles, and more preferably, the coupling agent used for coupling the antibody and the latex microsphere is a combination type coupling agent, and the combination type coupling agent comprises the following components: the mass ratio of the carbodiimide to the O-benzotriazole-N, N, N' -tetramethylurea tetrafluoroborate to the O-benzotriazole-tetramethylurea hexafluorophosphate is 1.2: 1.
In one embodiment, the antifreeze of the present invention is one or more of methanol, ethanol, ethylene glycol, water soluble amides and calcium chloride, brine, and the like. Preferably, the antifreeze agent in the present invention is ethylene glycol.
In a preferred embodiment, the kit of the invention comprises at least reagent 1 and reagent 2:
reagent 1
Figure BDA0003152844410000031
Reagent 2
Figure BDA0003152844410000032
Figure BDA0003152844410000041
The invention has the following beneficial effects:
1. the preparation steps of the specific substances in the kit are simple, the cost is low, and the kit is more suitable for industrial production and clinical popularization and application;
2. the applicant selects the surfactant F88 and the polyoxyethylene lauryl ether to be added in the kit by the combined screening of the surfactants, thereby obviously improving the analysis sensitivity and precision of the kit and enlarging the linear range of detection.
3. The glycol is added into the kit, so that the freezing resistance of the kit is improved, and the kit can be transported or stored at a low temperature and still maintain good detection performance.
Detailed Description
The following description of the preferred embodiments of the present invention is provided for the purpose of illustration and description, and is in no way intended to limit the invention.
Example 1: plotting of calibration curves
Reagent 1
Figure BDA0003152844410000042
Reagent 2
Figure BDA0003152844410000043
Figure BDA0003152844410000051
Reagent 1, reagent 2 and collagen calibrator were packaged into a kit.
Setting parameters on Hitachi-7180 full-automatic biochemical analyzer:
measurement mode End point method Sample size 6μl
Reagent 1 180μl Reagent 2 60μl
Measuring temperature 37℃ Wavelength of light 600nm
Optical path 1cm Reaction direction Is just
Procedure for the preparation of the
Figure BDA0003152844410000052
Figure BDA0003152844410000061
Calibration procedure
And calibrating by using an IV type collagen calibrator, performing multi-point calibration, and adopting a nonlinear calibration mode such as Logit, Spline and the like.
Calculation of results
And (5) five-point calibration, namely taking purified water from the first tube, and inputting a value of 0.0ng/ml, and taking a calibration product from the second tube to the fifth tube, and inputting a corresponding value. And making a dose/response curve according to the absorbance and the value of the calibrator, and calculating the content of the sample on the dose/response curve according to the absorbance value.
Example 2: determination of the Linear Properties
And (3) carrying out equal-difference mixed dilution on a certain sample (serum) with high IV type collagen concentration and a certain sample with low IV type collagen concentration, measuring the diluted concentration, measuring for three times, calculating the average value, comparing with the theoretical concentration, and calculating the linear deviation of the sample. It can be seen that the linear range of the kit can reach 30-420 ng/ml.
Linear result
Figure BDA0003152844410000062
Figure BDA0003152844410000071
Example 3: precision and recovery
Serum samples at high, medium and low concentrations (concentrations of 90, 180 and 360ng/ml, respectively) were assayed in 20 replicates and the assay data and data analysis are shown in the following table.
TABLE 5 precision and recovery
Figure BDA0003152844410000081
Figure BDA0003152844410000091
The latex immunoturbidimetry assay kit has the advantages of high accuracy, high recovery rate of 85-115%, high precision and no CV exceeding 10.0%.
Example 4 (comparative):
the validation was carried out using a combination of F88+ triton x100, and F88 single surfactant as a comparative example:
comparative example 1:
reagent 1
Figure BDA0003152844410000101
Reagent 2
Figure BDA0003152844410000102
Reagent 1, reagent 2 and collagen calibrator were packaged into a kit. Comparative example 2:
reagent 1
Figure BDA0003152844410000103
Reagent 2
Figure BDA0003152844410000111
Reagent 1, reagent 2 and collagen calibrator were packaged into a kit.
Linear results using a combination of F88 and TritonX100
Figure BDA0003152844410000112
Figure BDA0003152844410000121
Linear results using F88 alone
Figure BDA0003152844410000122
Figure BDA0003152844410000131
After calibration according to the procedure of example 1, the measurements for the linear range, the experimental parameters and the samples were identical to those of example 2, except that the reagents used were different: the results show that the linear range of the kit is only 30-330ng/ml (using F88+ triton x100), 30-250ng/ml (using F88 alone), much lower than the technical effect of the combination of F88 and polyoxyethylene lauryl ether, respectively, when a single surfactant is used.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is intended to include such modifications and variations.

Claims (6)

1. The kit is characterized by comprising a stabilizer, a buffer solution, an IV type collagen antibody, a surfactant and an antifreeze, wherein the surfactant is a combination of F88 and polyoxyethylene lauryl ether, the stabilizer is selected from one or more of inorganic salt, a preservative and a cell protective agent, the buffer solution is selected from one or more of phosphate buffer solution, trihydroxymethyl aminomethane sulfonic acid (TAPS) buffer solution and acetate buffer solution, the IV type collagen antibody is an antibody derived from animal or human artificial recombination, and the antifreeze is selected from one or more of methanol, ethanol, ethylene glycol, water-soluble amide, calcium chloride, saline and the like.
2. The kit of claim 1, wherein the surfactant is F88: polyoxyethylene lauryl ether ═ 1: 1-2: 1.
3. the kit of claim 1, wherein the inorganic salt is one or more of sodium chloride, potassium chloride or magnesium chloride, the preservative is one of Proclin 300, benzoic acid, sodium benzoate and sodium azide, and the cytoprotective agent is bovine serum albumin.
4. The kit of any one of claims 1 to 3, wherein the inorganic salt is sodium chloride, the preservative is Proclin 300, and the cryoprotectant is ethylene glycol.
5. The kit of claim 1 wherein said collagen iv antibody is a rabbit anti-human collagen iv antibody.
6. The kit of claim 1, wherein the kit comprises at least reagent 1 and reagent 2:
reagent 1
Figure FDA0003152844400000011
Figure FDA0003152844400000021
Reagent 2
Figure FDA0003152844400000022
CN202110768501.4A 2021-07-07 2021-07-07 IV-type collagen determination kit and preparation method thereof Active CN113552366B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110768501.4A CN113552366B (en) 2021-07-07 2021-07-07 IV-type collagen determination kit and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110768501.4A CN113552366B (en) 2021-07-07 2021-07-07 IV-type collagen determination kit and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113552366A true CN113552366A (en) 2021-10-26
CN113552366B CN113552366B (en) 2022-05-27

Family

ID=78131395

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110768501.4A Active CN113552366B (en) 2021-07-07 2021-07-07 IV-type collagen determination kit and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113552366B (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403716A (en) * 1991-01-10 1995-04-04 Teijin Limited Method for measurement of tissue factor in high sensitivity and measurement kit therefor
US20130115630A1 (en) * 2011-11-09 2013-05-09 Paul Shore Automated multiplex immunoassay
US20140127715A1 (en) * 2010-06-25 2014-05-08 Siemens Healthcare Diagnostics Inc. Reduction in false results in assay measurements
CN104685359A (en) * 2012-07-31 2015-06-03 积水医疗株式会社 Latex agglutination inhibition immunoassay
CN108490187A (en) * 2018-02-28 2018-09-04 山东博科生物产业有限公司 A kind of stabilization, sensitive four collagen type(IV-C)Detection reagent
CN111929434A (en) * 2020-06-16 2020-11-13 宁波瑞源生物科技有限公司 High-stability latex enhanced immunoturbidimetry determination kit
CN112240931A (en) * 2020-09-29 2021-01-19 中生北控生物科技股份有限公司 Immunity turbidimetry kit
CN112782409A (en) * 2020-12-31 2021-05-11 金华市强盛生物科技有限公司 Kit for determining IV type collagen in human blood and detection method

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403716A (en) * 1991-01-10 1995-04-04 Teijin Limited Method for measurement of tissue factor in high sensitivity and measurement kit therefor
US20140127715A1 (en) * 2010-06-25 2014-05-08 Siemens Healthcare Diagnostics Inc. Reduction in false results in assay measurements
US20130115630A1 (en) * 2011-11-09 2013-05-09 Paul Shore Automated multiplex immunoassay
CN104685359A (en) * 2012-07-31 2015-06-03 积水医疗株式会社 Latex agglutination inhibition immunoassay
CN108490187A (en) * 2018-02-28 2018-09-04 山东博科生物产业有限公司 A kind of stabilization, sensitive four collagen type(IV-C)Detection reagent
CN111929434A (en) * 2020-06-16 2020-11-13 宁波瑞源生物科技有限公司 High-stability latex enhanced immunoturbidimetry determination kit
CN112240931A (en) * 2020-09-29 2021-01-19 中生北控生物科技股份有限公司 Immunity turbidimetry kit
CN112782409A (en) * 2020-12-31 2021-05-11 金华市强盛生物科技有限公司 Kit for determining IV type collagen in human blood and detection method

Also Published As

Publication number Publication date
CN113552366B (en) 2022-05-27

Similar Documents

Publication Publication Date Title
CN102628864B (en) Kit for determining heart-type fatty acid binding protein in serum or urine by latex enhanced turbidimetric immunoassay
CN105548571A (en) Kit and method for detecting content of serum amyloid protein A and application
CN109738626A (en) NGAL latex immunoturbidimetry detection kit and preparation method thereof
CN103033619B (en) A kind of protein chip kit of comprehensive detection lung cancer marker and method
CN107656069A (en) Full-range C reactive protein quantitative detecting reagent and method in whole blood
EP2913670B1 (en) Method for increasing the sensitivity of immunoassay system through pretreatment of urine with denaturant
CN109633166A (en) A kind of people's α 1- microglobulin assay kit of highly sensitive, wide detection range
KR20170118858A (en) The immunological measurement method of L-FABP and the measurement reagent used in the method
JP5466405B2 (en) Method for measuring the molecular weight of hyaluronic acid
CN113552366B (en) IV-type collagen determination kit and preparation method thereof
CN108490187B (en) Stable and sensitive detection reagent for type IV-C collagen
JP3107474B2 (en) Method for quantification of components in lipoprotein fraction
Alber et al. Multicenter evaluation of the analytical and clinical performance of the Elecsys® S100 immunoassay in patients with malignant melanoma
WO2019171967A1 (en) Specimen diluent, method for preparing sample, sample, and sandwich method
CN103558398B (en) Anti-heparan-interference ischemia modified albumin detection reagent
EP3112863A1 (en) Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis
CN109444116A (en) A kind of enhanced ECL chemical illuminating reagent
CN113252909B (en) Preparation method of immunofluorescence detection kit based on quantum dots
CN112595845B (en) Hyaluronic acid detection kit and detection system
DE3920364C2 (en)
CN112198319A (en) Human immunoglobulin G4 kit with enhanced stability
WO2009017959A1 (en) Method of measurement of micronucleated erythrocyte populations
CN115856319B (en) Soluble growth stimulation expressed gene 2 protein determination kit, and preparation method and application thereof
CN106990057A (en) One kind 5 hydroxyindole acetic acid reagents of detection and preparation method
Jensen et al. Influence of freeze-drying on the clotting properties of fibrinogen in plasma

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant